The sector to back for the next decade

Big pharma is cheap and out of fashion. But it could prove very profitable over the next ten years, says Bengt Saelensminde. Here, he explains why, and picks the best way to invest in the sector.

As ever, Mr Market keeps toying with us. With the FTSE yo-yoing around 6000, it looks like a tug-of-war between a negative economy on the one side, versus Mervyn King and his free money on the other. This could go either way.

One thing is for certain though - after the run up we've seen over the last year, you would be mad not to take out some kind of insurance against a downswing.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Bengt graduated from Reading University in 1994 and followed up with a master's degree in business economics.

 

He started stock market investing at the age of 13, and this eventually led to a job in the City of London in 1995. He started on a bond desk at Cantor Fitzgerald and ended up running a desk at stockbroker's Cazenove.

 

Bengt left the City in 2000 to start up his own import and beauty products business which he still runs today.